[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![$1525b Graphic](https://lunarcrush.com/gi/w:26/t:$1525b.png) $1525b

Aptos sees $1.525B in token trading volume and 3.2M active wallets. Concerns arise over Moderna's revenue and high-speed rail project costs.

### About $1525b
Aptos ($1525b) is a cryptocurrency project.  

### Insights [#](/topic/$1525b/insights)
- $1525b sentiment near a 52-week low at XX.
- $1525b mentions is at X which is XXX% higher than it's daily average.
- $1525b creators is at X which is XXX% higher than it's daily average.
- $1525b creators is up XXXXXX% from the previous week.
- $1525b mentions is up XXX% from the previous week.

### Engagements: XXX [#](/topic/$1525b/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$1525b/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$1525b/time-series/interactions.tsv)  
**Current Value**: XXX  
**Daily Average**: XXXXX  
**1 Month**: XXXXXX -XX%  
**1-Year High**: XXXXXX on 2025-05-06  
**1-Year Low**: X on 2025-05-20  

| Social Network | X   |
| -------------- | -   |
| Engagements    | XXX |
  

  
  
### Mentions: X [#](/topic/$1525b/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$1525b/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$1525b/time-series/posts_active.tsv)  
**Current Value**: X  
**Daily Average**: X  
**1 Week**: XX +150%  
**1 Month**: XX +3.70%  
**1-Year High**: XX on 2025-05-24  
**1-Year Low**: X on 2025-04-28  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: X [#](/topic/$1525b/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$1525b/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$1525b/time-series/contributors_active.tsv)  
X unique social accounts have posts mentioning $1525b in the last XX hours which is up XX% from X in the previous XX hours
**Daily Average**: X  
**1 Week**: XX +117%  
**1 Month**: XX +33%  
**1-Year High**: X on 2025-05-24  
**1-Year Low**: X on 2025-04-28  
  
  
### Sentiment: XX% [#](/topic/$1525b/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$1525b/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$1525b/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XXX%  
**1 Month**: XXX% no change  
**1-Year High**: XXX% on 2025-05-23  
**1-Year Low**: XXX% on 2025-05-23  

**Most Supportive Themes**
- **Aptos and Exchange Activity:** (85%) Positive mentions of Aptos's trading volume, active wallets, and token holders, as well as the discussion of exchange futures open interest.
  
**Most Critical Themes**
- **Financial Concerns and Project Overruns:** (15%)  Concerns about Moderna's revenue decline and the high-speed rail project's cost overruns.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | XX       | X% | XXX     | XX% | X        | X% |
|         |          |    |         |     |          |    |
| Total   | XX       | X% | XXX     | XX% | X        | X% |
  


**Top assets mentioned**
In the posts about $1525b in the last XX hours

[Kaspa (KAS)](/topic/$kas)

**Top topics mentioned**
In the posts about $1525b in the last XX hours

[coins wallets](/topic/coins-wallets), [$213k](/topic/$213k), [holders](/topic/holders), [token](/topic/token), [1b](/topic/1b), [rev](/topic/rev), [$745share](/topic/$745share), [$1b](/topic/$1b), [$245b](/topic/$245b), [sol](/topic/sol), [$872b](/topic/$872b), [$1956b](/topic/$1956b), [$40159m](/topic/$40159m), [$104b](/topic/$104b), [approved](/topic/approved), [$95b](/topic/$95b), [combo](/topic/combo), [stocks technology](/topic/stocks-technology), [$131b](/topic/$131b), [league of legends](/topic/league-of-legends), [$157b](/topic/$157b), [$164b](/topic/$164b), [apt](/topic/apt), [usdt](/topic/usdt), [stablecoins](/topic/stablecoins), [$13b](/topic/$13b), [mcap](/topic/mcap), [$183t](/topic/$183t), [$980b](/topic/$980b), [$278t](/topic/$278t), [donald trump](/topic/donald-trump), [$676b](/topic/$676b), [$33b](/topic/$33b), [$106b](/topic/$106b), [kas](/topic/kas), [$197b](/topic/$197b), [$40m](/topic/$40m), [$kas](/topic/$kas), [$87b](/topic/$87b), [tariffs](/topic/tariffs), [$108b](/topic/$108b), [$38b](/topic/$38b)

### Top Social Posts [#](/topic/$1525b/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"6/ Numbers Dont Lie: 3.2M active wallets 42.7M token holders and $1.525B in token trading volume last week. All with just $2.13K in gas fees Aptos is the Usain Bolt of L1sspeed AND efficiency #AptosMetrics"  
[@dev_blanco1](/creator/x/dev_blanco1) on [X](/post/tweet/1946149269326483968) 2025-07-18 10:05:18 UTC 1209 followers, XX engagements


"BRPOutpost Estimates suggest the US collects $15-25B annually in federal taxes on tip income (income + payroll) based on $38B reported tips in 2018 and projections. This is much lower than the $108B net tariff receipts in FY2025's first X months (surpassing the $87B cited). Tariffs clearly generate far more revenue"  
[@grok](/creator/x/grok) on [X](/post/tweet/1945944080242069823) 2025-07-17 20:29:57 UTC 5.1M followers, XX engagements


"🚨Top XX Highest-Grossing Games Ever (All-Time Revenue) 🎮💰 X. Space Invaders $30B X. Pac-Man $25B X. Dungeon Fighter Online $22B X. Street Fighter II $21B X. Fortnite $20B X. Honor of Kings $18.6B X. PUBG $16.4B X. Lineage $15.7B X. League of Legends $15.25B XX. CrossFire $13.1B"  
[@Aismindiia](/creator/x/Aismindiia) on [X](/post/tweet/1945752207413887396) 2025-07-17 07:47:31 UTC 4084 followers, XX engagements


"2. Moderna ( $MRNA ) ★★★★ mRNA technology trailblazer. Key Strengths: Proprietary mRNA platform (COVID/flu combo vaccine in trials) Diversified pipeline (cancer vaccine mRNA-4157 Phase 3; rare disease therapies) $9.5B cash reserves (2024) Merck collaboration advancing oncology vaccines Growth Potential: Targeting XX approved products by 2027 Post-COVID revenue decline ($1.5-2.5B 2025E) poses near-term risk"  
[@ZhuhuiRiu](/creator/x/ZhuhuiRiu) on [X](/post/tweet/1945662331016355843) 2025-07-17 01:50:23 UTC XXX followers, XXX engagements